Janice Brown
Publications
- Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Bone Marrow Transplant. 2012; (4): 581-8
- Combined effects of interleukin-7 and stem cell factor administration on lymphopoiesis after murine bone marrow transplantation. Biol Blood Marrow Transplant. 2011; (1): 48-60
- Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Biol Blood Marrow Transplant. 2011; (5): 693-702
- Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. Bone Marrow Transplant. 2011; (2): 192-9
- Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2011; (2): 259-64
- A 39-year-old woman with lupus, myositis, and a recalcitrant vasculopathy. Arthritis Care Res (Hoboken). 2010; (9): 1351-6
- Utility of influenza vaccination for oncology patients. J Clin Oncol. 2010; (14): 2481-90
- Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis. 2008; (4): 535-9
- Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. J Infect Dis. 2008; (12): 1634-42
- The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood. 2008; (2): 945-53
- Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood. 2006; (1): 30-8
- Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature. Transpl Infect Dis. 2005 Sep-Dec; (3-4): 158-61
- Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. Curr Opin Infect Dis. 2005; (4): 352-8
- Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. J Infect Dis. 2005; (9): 1666-71
- Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2005; (1): 47-55
- Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2005; (7): 621-9
- Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. Blood. 2005; (9): 3535-7
- Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. J Immunol. 2005; (7): 4363-73
- The influence of the conditions of hematopoietic cell transplantation on infectious complications. Curr Opin Infect Dis. 2005; (4): 346-51
- Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis. 2004; (4): 347-52
- Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003; (2): 421-8
- Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. Blood. 2002; (13): 4660-7
- Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation. J Infect Dis. 2002; (1): 134-7
- Immunity to infections following hematopoietic cell transplantation. Curr Opin Immunol. 2001; (4): 451-7
- Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology. 1997; (1): 169-75
- Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis. 1995; (6): 1599-603
- Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol. 1995: 2151-60
Help
Trial Administration